David Einhorn
Greenlight Capital
Greenlight Capital Portfolio 13F
David Einhorn Holdings Activity
- Portfolio value:
- $1.64B≈ (+$151M≈)
- Previous value:
- $1.49B≈
- # of changes:
- 44
- New positions:
- 11
- Reported for:
- 31 Dec 2021 (Q4)
- Latest filing date:
- 14 Feb 2022
Greenlight Capital has disclosed a total of 44 changes to the portfolio in the (2021 Q4) SEC report(s): increased the number of shares of 7, bought 11 totally new, decreased the number of shares of 13 and completely sold out 13 position(s).
What stocks did David Einhorn buy in 2021 Q4?
During 2021 Q4 David Einhorn has bought 18 securities out of which top 5 purchases (by % change to portfolio) were (CHNG) Change Healthcare Inc (added shares +1.39%), (GPN) Global Payments Inc (new buy), (CPRI) CAPRI HOLDINGS LTD (added shares +45.71%), (ODP) ODP Corp (added shares +25.34%) and (LIVN) LIVANOVA PLC (added shares +92.11%).
What did David Einhorn invest in during 2021 Q4?
In the 2021 Q4 report(s) the following changes have been made to the top investments: (BHF) Brighthouse Financial, Inc (reduced shares -3.38%), (TECK) Teck Resources Ltd, CL-B (reduced shares -25.00%), (CHNG) Change Healthcare Inc (added shares +1.39%) and (AAWW) Atlas Air Worldwide Holdings (reduced shares -46.20%).
44 results
| History | Ticker | Name |
% or activity |
Shares change |
Shares held after* |
% change to portfolio |
Reported price* |
% difference current price* |
% of portfolio |
Held since* | Held for* |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
23Andme Holding Co
|
new
|
+98,122
|
98,122
|
+0.04%
|
$6.65
|
|
0.04%
|
2021 Q4
|
≈ 0.25 years
|
|
|
|
Astra Space Inc
|
new
|
+1,279
|
1,279
|
+0%
|
$6.25
|
|
0.00%
|
2021 Q4
|
≈ 0.25 years
|
|
|
|
FILANA THERAPEUTICS INC
|
new
|
+40,620
|
40,620
|
+0.11%
|
$43.70
|
-97.79%($0.97)
|
0.11%
|
2021 Q4
|
≈ 0.25 years
|
|
|
|
Civitas Resources Inc
|
new
|
+118,218
|
118,218
|
+0.35%
|
$48.97
|
|
0.35%
|
2021 Q4
|
≈ 0.25 years
|
|
|
|
WARNER BROS DISCOVERY INC
|
new
|
+652,000
|
652,000
|
+0.93%
|
$23.54
|
|
0.93%
|
2021 Q4
|
≈ 0.25 years
|
|
|
|
LAKEFRONT BIOTHERAPEUTIC-ADR
|
new
|
+185,000
|
185,000
|
+0.62%
|
$55.13
|
-52.41%($26.24)
|
0.62%
|
2021 Q4
|
≈ 0.25 years
|
|
|
|
Global Payments Inc
|
new
|
+506,000
|
506,000
|
+4.16%
|
$135.18
|
-34.58%($88.44)
|
4.16%
|
2021 Q4
|
≈ 0.25 years
|
|
|
|
Intel Corp
|
new
|
+309,500
|
309,500
|
+0.97%
|
$51.50
|
+97.56%($101.74)
|
0.97%
|
2021 Q4
|
≈ 0.25 years
|
|
|
|
Kyndryl Holdings Inc
|
new
|
+922,400
|
922,400
|
+1.02%
|
$18.10
|
-21.48%($14.21)
|
1.02%
|
2021 Q4
|
≈ 0.25 years
|
|
|
|
Proterra Inc
|
new
|
+15,070
|
15,070
|
+0.01%
|
$8.83
|
|
0.01%
|
2021 Q4
|
≈ 0.25 years
|
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.